Direxion Shares ETF Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| GOLDMAN FINANCIALCash or money market | 29.36% | $754.08K | 754,079 |
| DREYFUSCash or money market | 21.64% | $555.86K | 555,863 |
| REGENERON PHARMACEUTICALS INCREGN | 9.09% | $233.36K | 306 |
| AMGEN INCAMGN | 7.95% | $204.13K | 530 |
| VERTEX PHARMACEUTICALS INCVRTX | 7.84% | $201.34K | 422 |
| GILEAD SCIENCES INCGILD | 7.58% | $194.66K | 1,495 |
| ARGENX SE - ADRARGX | 6.98% | $179.30K | 210 |
| GOLDMAN SACHS LIQ ES FD ACash or money market | 6.23% | $160.00K | 160,000 |
| N/ADO | 2.83% | $72.66K | 1 |
| N/ADO | 0.62% | $15.90K | 1 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.